182 related articles for article (PubMed ID: 32293093)
1. Ribosomal Target-Binding Sites of Antimicrobial Peptides Api137 and Onc112 Are Conserved among Pathogens Indicating New Lead Structures To Develop Novel Broad-Spectrum Antibiotics.
Kolano L; Knappe D; Volke D; Sträter N; Hoffmann R
Chembiochem; 2020 Sep; 21(18):2628-2634. PubMed ID: 32293093
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal binding and antibacterial activity of ethylene glycol-bridged apidaecin Api137 and oncocin Onc112 conjugates.
Goldbach T; Knappe D; Reinsdorf C; Berg T; Hoffmann R
J Pept Sci; 2016 Sep; 22(9):592-9. PubMed ID: 27406684
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
Bluhm ME; Knappe D; Hoffmann R
Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
[TBL] [Abstract][Full Text] [Related]
4. Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity.
Brakel A; Krizsan A; Itzenga R; Kraus CN; Otvos L; Hoffmann R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328571
[TBL] [Abstract][Full Text] [Related]
5. Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.
Mardirossian M; Sola R; Degasperi M; Scocchi M
ChemMedChem; 2019 Feb; 14(3):343-348. PubMed ID: 30615305
[TBL] [Abstract][Full Text] [Related]
6. Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112.
Kolano L; Knappe D; Berg A; Berg T; Hoffmann R
Chembiochem; 2022 Mar; 23(5):e202100609. PubMed ID: 34902208
[TBL] [Abstract][Full Text] [Related]
7. Proline-rich antimicrobial peptide Api137 is bactericidal in porcine blood infected ex vivo with a porcine or human Klebsiella pneumoniae strain.
Krieger AK; Knappe D; Öhlmann S; Mayer L; Eder IB; Köller G; Hoffmann R; Rieckmann K; Baums CG
J Glob Antimicrob Resist; 2021 Mar; 24():127-135. PubMed ID: 33373733
[TBL] [Abstract][Full Text] [Related]
8. Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa.
Holfeld L; Knappe D; Hoffmann R
J Antimicrob Chemother; 2018 Apr; 73(4):933-941. PubMed ID: 29309652
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers for the accurate and sensitive diagnosis of three bacterial pneumonia pathogens using in silico approaches.
Bakare OO; Keyster M; Pretorius A
BMC Mol Cell Biol; 2020 Nov; 21(1):82. PubMed ID: 33218302
[TBL] [Abstract][Full Text] [Related]
10. Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.
Barksdale SM; Hrifko EJ; Chung EM; van Hoek ML
BMC Microbiol; 2016 Aug; 16(1):189. PubMed ID: 27542832
[TBL] [Abstract][Full Text] [Related]
11. Permeability enhancers sensitize β-lactamase-expressing Enterobacteriaceae and Pseudomonas aeruginosa to β-lactamase inhibitors, thereby restoring their β-lactam susceptibility.
Ferrer-Espada R; Sánchez-Gómez S; Pitts B; Stewart PS; Martínez-de-Tejada G
Int J Antimicrob Agents; 2020 Jul; 56(1):105986. PubMed ID: 32335279
[TBL] [Abstract][Full Text] [Related]
12. Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.
Knappe D; Ruden S; Langanke S; Tikkoo T; Ritzer J; Mikut R; Martin LL; Hoffmann R; Hilpert K
Amino Acids; 2016 Jan; 48(1):269-80. PubMed ID: 26334348
[TBL] [Abstract][Full Text] [Related]
13. Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome.
Seefeldt AC; Graf M; Pérébaskine N; Nguyen F; Arenz S; Mardirossian M; Scocchi M; Wilson DN; Innis CA
Nucleic Acids Res; 2016 Mar; 44(5):2429-38. PubMed ID: 26792896
[TBL] [Abstract][Full Text] [Related]
14. Expression and
Muthunayake NS; Islam R; Inutan ED; Colangelo W; Trimpin S; Cunningham PR; Chow CS
Biochemistry; 2020 Sep; 59(36):3380-3391. PubMed ID: 32840100
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analogues.
Szychowski J; Kondo J; Zahr O; Auclair K; Westhof E; Hanessian S; Keillor JW
ChemMedChem; 2011 Nov; 6(11):1961-6. PubMed ID: 21905229
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002.
Kiffer CR; Mendes C; Kuti JL; Nicolau DP
Diagn Microbiol Infect Dis; 2004 Jun; 49(2):109-16. PubMed ID: 15183860
[TBL] [Abstract][Full Text] [Related]
17. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich Antimicrobial Peptides Optimized for Binding to Escherichia coli Chaperone DnaK.
Knappe D; Goldbach T; Hatfield MP; Palermo NY; Weinert S; Sträter N; Hoffmann R; Lovas S
Protein Pept Lett; 2016; 23(12):1061-1071. PubMed ID: 27449938
[TBL] [Abstract][Full Text] [Related]
19. Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens.
Mardirossian M; Sola R; Beckert B; Valencic E; Collis DWP; Borišek J; Armas F; Di Stasi A; Buchmann J; Syroegin EA; Polikanov YS; Magistrato A; Hilpert K; Wilson DN; Scocchi M
J Med Chem; 2020 Sep; 63(17):9590-9602. PubMed ID: 32787108
[TBL] [Abstract][Full Text] [Related]
20. Catechol-bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents.
Karataş MO; Günal S; Mansur A; Alıcı B; Özdemir İ
Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000013. PubMed ID: 32301169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
